Medicaid Coverage Under Pressure: A new CMS rule on Medicaid work requirements and “medical frailty” exemptions is worrying patients with serious illness, with one North Carolina cancer survivor saying guidance could jeopardize her chemotherapy coverage. Hospital Safety & Quality: A U.S. study links COVID-era disruptions to a 23% rise in in-hospital deaths from C. difficile, especially when COVID and CDI occur together. NHS Access Strain: England’s first corridor-care figures show thousands of patients treated outside proper bed spaces each day, alongside worsening emergency department performance. Medicare Financial Outlook: Medicare trustees project the Hospital Insurance Trust Fund could become insolvent in 2033, citing revenue pressure and rising spending. Pricing Transparency Crackdown: The U.S. warns hospitals to comply with price transparency rules; Dosher Memorial Hospital says outdated formatting is being fixed after receiving a compliance letter. Public Hospital Oversight: An HSE audit in Ireland finds no structured system to monitor phasing out private practice in public hospitals, raising value-for-money and service risks. Maternal-Newborn Care Accountability: Bangladesh’s Ad-din Hospital license was revoked after six newborn deaths, with officials citing “unusual circumstances” and negligence findings. Fraud Prevention Push: Ohio’s governor announced new Medicaid fraud prevention initiatives, including a provider moratorium and payment suspensions for high-risk providers. Biotech & Pharma Pipeline: Medicenna secured new U.S. patents for its IL-4/IL-13 Superkine platform; Purple Biotech presented new preclinical IM1240 data; and Eyam Health graduated from CDL with large-animal proof for its Gemini genetic medicine platform.